Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers
Clinical trial NCT01440686 · COMPLETED
Trial details
- NCT number
- NCT01440686
- Sponsor
- HanAll BioPharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2011-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.